• Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) versus Placebo
Looking for something? So are we – people with memory or thought processing problems.

Have you noticed a gradual decline in your memory? Could you have mild Alzheimer’s disease? Are you between 55 and 90 years of age?

We understand that this may be a worrying time and that you might be thinking about what to do next. If this sounds like you, consider EXPEDITION 3 – a clinical research study looking at an investigational drug for mild Alzheimer’s disease. Study-related treatments and procedures will be free of charge.

Call (617) 855-2649 to learnmore and find a study center near you.
Institution  –  McLean Hospital, Belmont, MA
Principal Investigator  – James M Ellison, MD
Enrollment Information
For further information about enrolling a patient in this trial, contact the person below.
Name  – Lauren C Almeida, CRC
Phone  – 617-855-2649